EUVIMED · CrossrefJournal
Advances in Therapy
ISSN 0741-238X · Springer Science and Business Media LLC
Latest articles
Beyond Bicarbonate: Renal Replacement Therapy in Refractory Diabetic Ketoacidosis: A Narrative Review
Could Results from the VESALIUS-CV Trial Change the Current Management of Dyslipidemia by Primary Care Clinicians?
Estimating Prevalence of Early Symptomatic Alzheimer’s Disease and the Demand for amyloid-targeting therapies in China: A Meta-analysis and Modelling Study
Correction: A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity
Retrospective Analysis of Disease Burden, Treatment Patterns, and Healthcare Resource Utilization in Patients with Ulcerative Colitis in Dubai, UAE
Safety and Effectiveness of Lisdexamfetamine Dimesylate in Paediatric Attention-Deficit/Hyperactivity Disorder Assessed by Physicians and School Teachers: A Post-marketing Surveillance Study
Real-World Characteristics, Treatment Patterns, and Outcomes of Patients with Mantle Cell Lymphoma After Receiving Covalent Bruton Tyrosine Kinase Inhibitors in China
The Patient Journey in Tenosynovial Giant Cell Tumor: A Narrative Review of the Real-Life Experience
Vamorolone for DMD: Clinical Pharmacology of a Novel Dissociative Corticosteroid, A Narrative Review
DISC-OSA: A European Delphi Consensus on OSA Screening in People with Obesity
Sustained Anlotinib-Based Combination Therapy Beyond Progression in Advanced Soft Tissue Sarcoma: A Large Multicenter Real-World Study
Association Between Immune Checkpoint Inhibitors and the Hazard of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer Included in the French Real-Life ESME Cohort
The Societal Burden of Sickle Cell Disease: A Life Course Perspective
Sustainability Strategies and Practices in the Management of Chronic Kidney Disease: A Narrative Review
Economic and Humanistic Burden of Cardiovascular Comorbidity in Kidney Failure: Findings from a Systematic Literature Review
Baseline Choroidal Vascularity Index and Short-Term Choroidal Structural Change Following Faricimab in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration
Evolution of Automated Insulin Delivery Devices in the Era of Artificial Intelligence: A Narrative Review
Stepping up from ICS/LABA to FF/UMEC/VI in Patients with Uncontrolled Asthma: Outcomes from the 52-Week PERFORM Pragmatic Randomized Controlled Trial
Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients with Bipolar I Disorder
Real‑World Treatment Patterns in Endometrial Cancer in the Post-Immune Checkpoint Inhibitor and Post-Platinum-Based Chemotherapy Setting in the United States
Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients with Schizophrenia
Mechanisms Behind the Disease: Understanding the Role of APRIL in IgAN Pathogenesis: A Podcast
Epidemiology, Complications, and Management of Complications of Achondroplasia: A Systematic Literature Review and Meta-analysis
Real-World Impact of Maralixibat Treatment on Concomitant Medication Use in USA-Based Patients with Alagille Syndrome and Cholestatic Pruritus: A Retrospective Analysis
Measuring the Effect of Amphetamine Extended-Release (DYANAVEL® XR) on Driving Performance in Young Adult Drivers with ADHD Using a Sophisticated Driving Simulation
Efficacy and Safety of Dapagliflozin, Glimepiride, and Metformin Fixed-Dose Combination Tablet in Type 2 Diabetes: A Phase III Trial
Teclistamab Plus Daratumumab Versus Standard Daratumumab-Based Proteasome Inhibitor Combinations for Relapsed/Refractory Multiple Myeloma: An Inverse Probability of Treatment Weighting Analysis
Expert Consensus on the Clinical Application of Sulodexide in Vascular Diseases
Real-World Assessment of Healthcare Resource Utilization-Defined Manic and Depressive Events Among Patients with Bipolar I Disorder Treated with Cariprazine Versus Aripiprazole
Cost Per Remission of Vedolizumab Versus Risankizumab for the Treatment of Moderately to Severely Active Crohn’s Disease in Italy
EUVIMED